33295-35-1 Usage
Uses
Used in Organic Synthesis:
7-Bromo-1-methylnaphthalene serves as a crucial intermediate in organic synthesis, playing a pivotal role in the production of a variety of pharmaceuticals and agrochemicals. Its unique structure allows for its use in creating complex organic molecules that are vital for these industries.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 7-Bromo-1-methylnaphthalene is utilized as a building block for the synthesis of specific drugs. Its presence in the molecular structure can impart desired therapeutic properties, making it an essential component in drug development.
Used in Agrochemical Development:
Similarly, in agrochemicals, 7-Bromo-1-methylnaphthalene is employed for the synthesis of compounds that can be used in pest control and crop protection. Its chemical properties make it suitable for creating effective and targeted agrochemicals.
Used in Research and Development:
7-Bromo-1-methylnaphthalene is also a valuable asset in the research and development of new chemical compounds. Its unique characteristics make it a subject of interest for scientists exploring novel applications and properties in various chemical domains.
Check Digit Verification of cas no
The CAS Registry Mumber 33295-35-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,2,9 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 33295-35:
(7*3)+(6*3)+(5*2)+(4*9)+(3*5)+(2*3)+(1*5)=111
111 % 10 = 1
So 33295-35-1 is a valid CAS Registry Number.
33295-35-1Relevant academic research and scientific papers
(PIPERIDIN-3-YL)(NAPHTHALEN-2-YL)METHANONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HISTONE DEMETHYLASE KDM2B FOR THE TREATMENT OF CANCER
-
, (2016/08/10)
The present invention relates to (piperidin-3-yl)(naphthalen-2-yl) methanone derivatives and related compounds as inhibitors of one or more histone demethylses, such as KDM2b. The invention also provides pharmaceutically acceptable compositions comprising
Diastereoselective synthesis of β-aryl-C-nucleosides from 1,2-anhydrosugars
Singh, Ishwar,Seitz, Oliver
, p. 4319 - 4322 (2007/10/03)
(Chemical Equation Presented) The cis opening of glycal epoxides with arylaluminum reagents provides strict stereocontrol in C-glycosylation. β-Aryl-C-2-deoxynucleosides are obtained from known glycals by an epoxidation-glycosylation-deoxygenation sequenc
